History of West in Singapore
West Pharmaceutical Services was established in 1923 as The West Company, and has become a global leader in the design and manufacture of products and services for the pharmaceutical and health care industries. In keeping pace with today's needs, West has developed a range of pharmaceutical packaging products and services, medical device components and assemblies produced from elastomers, metal and plastic.
West in Singapore
West established a wholly owned subsidiary in Singapore on 8 January 1982, strategically positioning the company to support customers in the Asia Pacific region. Operating from a 20,000 square meter facility in Jurong, West Pharmaceutical Services Singapore employs sophisticated technologies to manufacture pharmaceutical elastomeric closures, medical device components and metal seals for pharmaceutical use. Singapore is the regional office for its Asia Pacific region and employs 500 staff. It strongly believes that people are its core assets and people development is key to the current and future of the organization in meeting the needs of its customers.
In addition to providing market-leading products, West’s commitment to European customers is clearly demonstrated by the resources applied to provide technical support to our customers. The Technical Support group, based in Germany, is mostly staffed with experienced chemists and engineers whose knowledge help customers to make component selections and who support customers’ technical needs throughout their products’ life cycle.
Shaping the Future
In the first years of the 21st century, West invested significantly in all European facilities to upgrade cGMP, capacity and technology. These investments have added manufacturing and processing capacity, and new equipment and technologies that improve quality and meet customer demand for increased levels of precision.
The additional investments in plants in Le Nouvion, France, and Eschweiler, Germany, enabled the introduction of new manufacturing technologies. Installations included new pharmaceutical washers, clean rooms and systems for producing Water for Injection, which added capacity to the three existing washing lines. The new finishing lines are especially important because they will enable West to satisfy customer demand for clean products.
In 2004, West completed a 4,000-square-meter expansion of the plant in Stolberg, Germany. The added space accommodates manufacturing capacity to satisfy current and anticipated sales growth in pharmaceutical seals and TrimTec closures. The addition also includes a new raw materials warehouse and a tooling maintenance shop. The Stolberg plant is a potential site for manufacturing West Spectra ID products and Flip-Off CCS seals. West Spectra ID seals display vital information such as a vial’s contents, brand name, point-of-use instructions, and dosage or strength of the medicine. West Spectra ID can help identify products as genuine and establish and protect brand identity.
West strengthened its position as a leader in the global markets for pharmaceutical and health care delivery systems with two acquisitions in 2005. In May, West acquired The Tech Group, a U.S.-based plastic injection moulding company with a facility in Dublin, Ireland.
In August 2005, West acquired Medimop Medical Projects, Ltd., a company based in Israel that designs and manufactures systems and devices for mixing, transferring, reconstituting and administering injectable drugs.
In 2009, West purchased the drug delivery device business assets of Plastef Investissements SA, and obtained the right to manufacture the Eris safety syringe, a passive safety system for use with fixed or staked needle prefillable syringes. The Eris system complements West's NovaGuard passive safety needle, which was recently introduced to the market for use with luer-lock syringes.
Also in 2009, West dedicated its first manufacturing plant in China, located in the Shanghai Qingpu Industrial Zone (SQIZ). The plant, which manufacturers TrimTec® and InsoCap® closures for intravenous bottles, was established in direct response to client demand and helps solidify West’s status as a global, cutting-edge company committed to supporting the growth of the Company’s pharmaceutical customers in China.